NEW HOPE, Pa., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc. (“Orchestra BioMed”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing ...
SHANGHAI, June 15 (Reuters) - China's Harbour BioMed said on Monday it would focus on another patent infringement case with ...
Orchestra BioMed has announced that the FDA has granted Breakthrough Device Designation for its atrioventricular interval modulation (AVIM) therapy, aimed at treating over 7.7 million U.S. patients ...
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with ...
Harbour BioMed and BioMap will build a globally leading AI-driven complex biologics AIDD infrastructure platform for ...
View Orchestra BioMed Holdings, Inc. OBIO stock quote prices, financial information, real-time forecasts, and company news from CNN.
- BioMed Realty Continues to Support California’s Life Science Industry Growth with $2.6 Billion Capital Commitments in Last Four Years SAN DIEGO--(BUSINESS WIRE)--BioMed Realty (“BioMed”), a leading ...
BioMed Realty Trust continues to push the life sciences conversion wave in Boston, quietly taking over two prominent development sites. The Blackstone-backed life sciences investor has entered a ...
One of the biggest real estate investors in the world just made a deal that reinforces how the life sciences industry has been supercharged by the coronavirus pandemic. The internal transaction is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results